Gentiva Health Services, Inc. (NASDAQ:GTIV)

Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.

Nov 13 $10.00 strike at $1.10 has 16% discount and 20% annualized return.

May soon be non-compliant with various financial covenants in loan documents.

if itsmells like a value trap it probably is. Never-the-less, it's cheap

Their high debt load combined with increasing uncertainty with medicare payments is going to either cause this company to either go out of business or shrink since they can't possibly sustain the situation with deteriorating fundamentals.

health

Gentiva is moving up fast every day. A 10+ dollar stock (minimum) in the $4 range? Yes please.

Exploded once it hit 3.90, and meeting resistance at 5.30 today. I think there will be a move to 5.30 tomorrow and if it gets there it could take off big again.

It is now undervalued. Every bad thing that could ever happen has happened. It is not about cash flow. People in Greece can fart all they want and it can't drop much more. Upside is big percentage-wise.

bargain?

Wow this looks cheap. The market has overreacted and it is time to pick this one up while it is on sale. It's trading below half of book value and the brand name alone is enough to warrant a buyout. I am in.

P-Worm

Wonder if I can catch this falling knife?

Bouncing back after a recent decline.

Gentiva Health Services is being added to the limit buy list to join Amedisys, but to be clear Amedisys appears marginally a better value of the two, thus the limit buy order on Gentiva further away from its current price as opposed to Amedisys. Gentiva dipped below its book value today and has lost almost 1/3rd of its value on news that the SEC is investigating the way home health company's bill and collect revenues. I think this will result in yet another hand slap for the industry and will have little to no material impact on the sector. Fear and panic have swept in to drag down GTIV but trading at roughly 7.5 times forward profits there is plenty to be cheery about. Long-term growth rates here are 7% so the PEG is right in line if not below the industry average and although they are 55M in the debt hole, they are churning nearly 100M in gross profits each year, so this doesn't worry me one bit. I'm placing a limit buy order at $14.94 and attempting to nab a falling knife at roughly 5.5 times forward numbers and only 0.75 times book value if it hits.

UltraLong

Technical--Chart

A huge, federal Fair Labor Standards Act (FLSA), class action suit, filed by employees, may drain Gentiva's cash and produce negative confidence in the minds of potential patients, clients, and investors. Employees in NY and NC are included in the suit. When will employees from other states file?

running a new screen.

I think this stock is about 60% undervalued. Whatever health care legislation is passed, I don't believe it will hurt the earnings for this home health care company.

Gentiva Health Services has low P/E, low P/S, and low P/CF ratios. Additionally, it's low D/E, Net Profit Margin ratios indicate that it's an undervalued company that is poised to grow over time w/ strong financial report.

Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 4/27 picks.